Answers are grounded in this paper and cite their sources.
Rapid, accurate and robust glucose measurements are needed to make a safe artificial pancreas for the treatment of diabetes mellitus type 1 and 2. The present gold standard of continuous glucose sensing, subcutaneous (SC) glucose sensing, has been claimed to have slow response and poor robustness towards local tissue changes such as mechanical pressure, temperature changes, etc. The present study aimed at quantifying glucose dynamics from central circulation to intraperitoneal (IP) sensor sites, as an alternative to the SC location.
No takes yet. Share an insight, caveat, or question.
Fougner et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: